Modulation of cytosolic calcium levels in osteoblast-like osteosarcoma cells by olpadronate and its amino-derivative IG-9402

Calcified Tissue International

Volumn 72, Issue 3, 2003, Pages 215-221

  Vazquez, G ^a   Santillan, G ^a   Boland, R ^a   Roldan E ^b   Perez Lloret A ^b  

^a UNIVERSIDAD NACIONAL DEL SUR   (Argentina)

^b Gador SA   (Argentina)

Author keywords

Bisphosphonates; IG 9402; Intracellular Ca2+; Olpadronate; Osteoblasts

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 3 (N,N DIMETHYLAMINE) 1 AMINOPROPYLIDENE BISPHOSPHONATE; BISPHOSPHONIC ACID DERIVATIVE; CALCITRIOL; CALCIUM; IG 9402; NEOMYCIN; NIFEDIPINE; OLPADRONIC ACID; OSTEOCALCIN; THAPSIGARGIN; UNCLASSIFIED DRUG; VERAPAMIL;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; NONHUMAN; OSTEOBLAST; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN SECRETION; RAT;

ANIMALS; CALCITRIOL; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CALCIUM SIGNALING; CHICK EMBRYO; CYTOSOL; DIPHOSPHONATES; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRENES; NEOMYCIN; NIFEDIPINE; OSTEOBLASTS; OSTEOCALCIN; OSTEOSARCOMA; PHOSPHOLIPASE C; PYRROLIDINONES; RATS; THAPSIGARGIN; TUMOR CELLS, CULTURED; VERAPAMIL;

EID: 0042267817     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-002-1070-1     Document Type: Article

References (23)

1. Fleisch H (1997) Bisphosphonates in bone disease: from laboratory to patient, 3rd ed. The Parthenon Publishing Group, New York, NY, USA
2. Civitelli R, Kim YS, Gunsten SL, Fujimori A, Huskey M, Avioli LV, Hruska KA (1990) Nongenomic activation of the calcium message system by vitamin D metabolites in osteoblast-like cells. Endocrinology 127:2253-2262
3. Sunberg R, Ebetino FH, Mosher CT, Roof CF (1991) Designing drugs for stronger bones. Chemtech 21:304-309
4. Van Beek E, Pieterman E, Cohen L, Lowik C, Papapoulos S (1999) Farnesyl pyrophosphate synthase is the molecular target of nitrogen-containing bisphosphonates. Biochem Biophys Res Commun 264:108-111
5. Van Beek E, Lowik C, Que I, Papapoulos S (1996) Dissociation of binding and antiresorptive properties of hydroxybisphosphonates by substitution of the hydroxyl with an amino group. J Bone Miner Res 11:1492-1497
6. Brown RJ, Van Beek E, Watts DJ, Lowik C, Papapoulos S (1988) Differential effects of aminosubstituted analogs of hydroxy bisphosphonates on the growth of Dictyostelium discoideum. J Bone Miner Res 13:253-258
7. Luckman SP, Hughes DE, Coxon FP, Graham R, Russell MJ, Rogers MJ (1998) Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent posttranslational prenylation of GTP-binding proteins, including Ras. J Bone Miner Res 13:581-589
8. Opas EE, Rutledge SJ, Golub E, Stern A, Zimolo Z, Rodan GA, Schmidt A (1997) Alendronate inhibition of protein-tyrosine-phosphatase-meg1. Biochem Pharmacol 54:721-727
9. Skorey K, Ly HD, Kelly J, Hammond M, Ramachandran Z, Huang Z, Gresser MJ, Wang Q (1997) How does alendronate inhibit protein-tyrosine phosphatases? J Biol Chem 272:22472-22480
10. Fleisch H (1998) Bisphosphonates: mechanism of action. Endocrine Rev 19:80-100
11. Rogers MJ, Frith JC, Luckman PS, Coxon FP, Benford J, Monkkonen J, Auriola S, Chilton KM, Russell RG (1999) Molecular mechanisms of action of bisphosphonates. Bone 24:73S-79S
12. Plotkin LI, Weinstein RS, Parfitt AM, Manolagas SC, Bellido T (1999) Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest 104:1363-1374
13. Mathov I, Sgarlata CL, Plotkin LI, Leoni J, Bellido TM (2001) ERKs and calcium channels are involved in the proliferative effect of bisphosphonates on osteoblastic cells in vitro. J Bone Miner Res 11:2050-2056
14. 2+ influx in skeletal muscle cells. J Biol Chem 273:33954-33960
15. Snedecor G, Cochran W (1967) Statistical methods. Iowa State University Press, Ames, IA
16. Lieberherr M (1987) Effects of vitamin D metabolites on cytosolic free calcium in confluent mouse osteoblasts. J Biol Chem 262:13168-13173
17. 2+-ATPase. Proc Natl Acad Sci USA 87:2466-2470
18. 3 modulate the hormone-induced increments in osteocalcin gene expression in osteoblastic-like cells. J Cell Biochem 50:124-129
19. 3 signal response pathways in osteoblasts: cross-talk between genomic and membrane-initiated pathways. Am J Kidney Dis 31:729-742
20. 2+ entry: toward a proliferation or a simplification? FASEB J 6:3085-3091
21. 3 receptor in osteoblast-like cells. FEBS Lett 270:165-167
22. Guggino SE, Lajeunesse D, Wagner JA, Snyder SH (1989) Bone remodelling signaled by a dihydropyridine- and phenylalkylamine-sensitive calcium channel. Proc Natl Acad Sci USA 86:2957-2960
23. Suda T, Nakamura I, Jimi E, Takahashi N (1997) Regulation of osteoclast function. J Bone Miner Res 12:869-879